Navigation Links
PDI Reports 2009 Third Quarter Financial Results
Date:11/5/2009

er 2009

For the quarter ended September 30, 2009, net revenue totaled $21.0 million, compared to $24.5 million in the same period last year. Revenue in the Sales Services segment for the third quarter of 2009 was $17.8 million, compared to $20.0 million in the same period of 2008. While Sales Services has gained revenue as a result of new contracts and the expansion of existing contracts, these gains were more than offset by lost revenue from the internalization of a contract sales force by a long-term client and the expiration or termination of other sales force arrangements in effect during 2008. Revenue in the Marketing Services segment for the third quarter of 2009 was $5.1 million compared to $4.5 million in 2008. A 30% increase in our Pharmakon business unit due to an increase in the number of projects was partially offset by a decrease in revenue from closing the VIM business unit in 2009.

Gross profit for the third quarter of 2009 was $6.9 million compared to $0.4 million in the same period last year. Gross profit for the Sales Services segment increased to $4.3 million from $2.8 million last year and gross profit in the Marketing Services segment increased to $2.4 million from $1.7 million in the year ago period. The impact on gross profit of lower revenue in the Sales Services segment was more than offset by lower operating costs, in large part resulting from the Company's cost savings initiatives as well as the recognition of higher performance related fees in 2009. The increase in gross profit in the Marketing Services segment was primarily attributable to higher revenue from our Pharmakon business unit. The Company's third quarter 2008 gross profit was negatively impacted by $4.1 million from the execution of the product commercialization agreement which was mutually terminated in the second quarter of 2009.

Total operating expenses for the third quarter of 2009 were $11.4 million compared to $10.0 million in t
'/>"/>

SOURCE PDI, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
2. Symmetry Medical Reports Third Quarter 2009 Financial Results
3. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
4. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
5. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
6. HeartWare International Reports Third Quarter Revenues of $7.5 Million
7. Varian, Inc. Reports Fourth Quarter 2009 Results
8. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
9. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
10. Cambrex Reports Third Quarter 2009 Results
11. Regeneron Reports Third Quarter 2009 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... three months ended March 31, 2015 and reaffirmed its ... for 2015. First Quarter 2015 Highlights Include: ... increase of 72% as compared to $10.9 million for ... adjusted non-GAAP EBITDA of $11.5 million, an increase of 170% ...
(Date:5/5/2015)... May 5, 2015 Tissue ... Group"), the regenerative medical devices company, announces that ... regional distribution contract for DermaPure® which is used ...      (Logo: http://photos.prnewswire.com/prnh/20150505/743321) , ... since Tissue Regenix received notice of Local Coverage ...
(Date:5/5/2015)... , May 5, 2015  Stryker Orthopaedics announced ... Ponte Vedra, FL.  Since becoming the ... Champions Tour" over one year ago, the company has ... Tour combined, with its onsite activation the Stryker Mobility ... on the importance of joint health. Proving to be ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 2ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 3ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 4ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 5ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 6ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 7ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 8ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 9Tissue Regenix Group plc: US Regional Distribution Agreement Signed 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 3
... following is a statement of Matthew L. Myers, ... http://photos.prnewswire.com/prnh/20080918/CFTFKLOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ... and Drug Administration for taking appropriate enforcement action ... various violations of the Federal Food, Drug and ...
... Sept. 9 The U.S. Food and Drug ... Chloride (pralidoxime chloride), a drug used to treat ... agents). The drug is approved to be administered ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ...
Cached Medicine Technology:FDA Takes Appropriate Action to Regulate Electronic Cigarettes and Protect Public Health 2FDA Approves Pediatric Use of Chemical Poisoning Treatment 2
(Date:5/5/2015)... Burnie, MD (PRWEB) May 05, 2015 ... in an upcoming episode of Innovations with Ed Begley ... and show times TBA. , This segment will focus ... home testing. Viewers will learn about their AccuSom® home ... sleep test that provides continuous patient support and next-day ...
(Date:5/5/2015)... 2015 After record-breaking sales of ... Walgreens introduces the Cookies & Cream flavor at stores ... Nutrition has continually raised the bar for nutritional snacks. ... with an unprecedented nutritional profile, backed by international patents ... Nutrition will launch additional new products and expand retail ...
(Date:5/5/2015)... After conducting a nationwide executive search ... Smith, West Holt Medical Services in Atkinson, ... A skilled healthcare executive with more than 10 years ... on June 1st. , “Brad brings a proven track ... understanding and success in building strong relationships with physicians,” ...
(Date:5/5/2015)... Louis, MO (PRWEB) May 05, 2015 The ... 12, 2015 from 5:00 to 8:00 pm at the Rochester ... 50 hospitals, clinics and groups with career opportunities will be ... Attendees will enjoy free hors d’oeuvres and raffle prize drawings. ... says, “Rochester is an ideal location to hold a ...
(Date:5/5/2015)... Cincinnati, OH (PRWEB) May 05, 2015 ... healthcare ministry serving Ohio and Kentucky – has devoted ... Be Well videos to childhood obesity issues. Experts say ... In a concise video on Mercy Health’s YouTube channel, ... ,     Why is childhood obesity worse now ...
Breaking Medicine News(10 mins):Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:West Holt Medical Services Hires New Chief Executive Officer 2Health News:West Holt Medical Services Hires New Chief Executive Officer 3Health News:PracticeMatch to Host Physician Career Fair at the Rochester Marriott on May 12, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Rochester Marriott on May 12, 2015 3Health News:Videos provide helpful information about childhood obesity 2
... on the target areas, where ADHD drugs act, researchers ... (PFC) region of the brain //rather than on accumbens ... University of Wisconsin-Madison found how the drug Ritalin used ... (ADHD), works in the brain. ,But ...
... with prostate cancer are more influenced by anecdote, misconception ... on clinical trial evidences. ,Research showed ... anecdotal experiences of others with prostate cancer to their ... entirely different from them are the reasons for waving ...
... Rheumatoid arthritis are also prone to have sexual problems. The ... against rheumatism congress. ,Rheumatoid arthritis occurs in elderly ... and inflammation of the joints. It is a chronic disease ... ,According to the study it was found that ...
... that was begun some six years ago has finally begun ... by mobile doctors //thereby getting the care they need without ... of a 33-foot-vehicle that would travel to schools in Garland, ... This has helped teens to get the care they need ...
... properly funding the cholesterol lowering drugs to the new Zealanders. ... which they point out the shortsighted approach of the agency ... and Dr Harvey White said that the agency did not ... years. ,Statins are drugs which help in the ...
... P. Viswanatham Government Medical College Hospital not in the list ... // ,There is an increased bitterness among the ... ministry of health of not including K. A. P. Viswanatham ... with the ,All India Institute of Medical Sciences (AIIMS), New ...
Cached Medicine News:Health News:Effect of ADHD Drugs on the Brain - Study Finds 2Health News:Effect of ADHD Drugs on the Brain - Study Finds 3Health News:Misconception on Treatment Options among Prostate Cancer Patients 2Health News:Increased Demand For Up-gradation Local Hospital In Tiruchy 2
Inorganic phosphorus reagent is used for the quantitative determination of inorganic phosphorus in human serum....
Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum....
For the kinetic quantitative determination of g-Glutamyl Transferase in serum for manual and/or automated procedures....
g-GT Liquid Reagent (Kinetic Method). Wavelength: 405 nm. Linear range: 0-200 U/mL. Prepare Working Reagent in the ratio of 5 parts R1 to 1 part of R2, (i.e., 50 mL R1 and 10 mL R2)....
Medicine Products: